Genmab — Januar 2022
-
Fredagens aktier: Netcompany var et lille lyspunkt i rødt marked
https://www.proinvestor.com/investornyt/772951/fredagens-aktier-netcompany-var-et-lille-lyspunkt-i-rodt-marked -
Oppe med 3,5 % i USA. https://finance.yahoo.com/quote
/GMAB?p=GMAB&.tsrc=fin-srch -
Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Genmab A/S (GMAB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Yahoo Finance (finance.yahoo.com)
-
Immunotherapy Shakes Up Cervical Cancer Treatment Paradigm https://www.onclive.com/view/immunotherapy-shakes-up-cervical-cancer-treatment-paradigm
-
God morgen.
-
God morgen.
-
US i går: Dow Jones industrigennemsnittet endte 1,38 procent til 34.651,87 point.
Det brede S&P 500-indeks steg 2,18 procent og endte på 4.426,21 point.
Teknologiindekset Nasdaq endte stærkt med en stigning på hele 3,13 procent til 13.729,92 point. -
US: Bevægelser
Blandt sværvægterne på S&P 500 steg Visa 10,4 procent, og Mastercard sakket bagud med en kursudvikling på 8,9 procent.
VIX-indekset, også kendt som frygtindekset, faldt med 9,18 procent.
Den 10-årige statsrente i USA, også kendt som den 10-årige, faldt med 1,38 procent ved børslukningen.
-
Kesimpta also saw a 5% price increase. Dara same for SC and IV (5.4%), Rybrevant also 5.4% , Tepezza only 1.9% via https://www.46brooklyn.com/branddrug-boxscore
-
Ny forskning. Hexabody mod lungebetændelse https://www.biorxiv.org/content/10.1101/2022.01.21.477211v1.full
-
interesting, wondering why they are investigating this... could this be a clue https://www.news-medical.net/news/20210729/Streptococcus-pneumoniae-modulates-host-immunity-to-SARS-CoV-2.aspx
-
Kesimpta godkendt til behandling i DK. https://sundhedspolitisktidsskrift.dk/nyheder/5803-medicinradet-anbefaler-ny-sklerosebehandling-i-danmark.html
-
-
Clinical development of candidate vaccines for S. aureus, C. difficile, P. aeruginosa, ExPEC and N. gonorrhoeae has so far failed....Compared with a few years ago, we now have a much better understanding of the contribution of functional antibodies, cell-mediated immunity and innate immunity in mediating protection against these pathogens
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind